Trial intelligence / Profile preview

Dexmedetomidine on Postoperative Cognitive Function in Shoulder Arthroscopy

NCT02643017Completed

Sponsor
Yonsei University
Start
Dec 2015
Primary completion
Aug 2018
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial in Post-operative cognitive dysfunction (POCD) comparing Dexmedetomidine with Placebo (2 arms). Primary endpoints: Number of patients with postoperative cognitive decline assessed by mini-mental state examination and Number of patients with postoperative cognitive decline assessed by a battery of psychometric test. Started Dec 2015; status: completed.

02

Drugs

dexmedetomidine
03

Conditions

Post-operative cognitive dysfunction (POCD)

Beyond the preview

Go deeper on NCT02643017.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02643017.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call